Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease.
Signal Transduct Target Ther
; 6(1): 212, 2021 05 29.
Article
in English
| MEDLINE | ID: covidwho-1387227
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Oleanolic Acid
/
Coronavirus 3C Proteases
/
SARS-CoV-2
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Signal Transduct Target Ther
Year:
2021
Document Type:
Article
Affiliation country:
S41392-021-00628-X
Similar
MEDLINE
...
LILACS
LIS